Mylan

This is a preliminary report on Mylan’s security posture. If you want in-depth, always up-to-date reports on Mylan and millions of other companies, consider booking a demo with us. UpGuard is the new standard in third-party risk management and attack surface management. Our security ratings engine monitors billions of data points each day.

UpGuard Security Rating

${grade.letter}
${cstarScore}
/ 950
UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely Mylan has good security practices.

Company info

Mylan
Company
Mylan
Employees
Location
CEO
Heather Bresch
Last updated
Last updated
Industries
Last updated today

Security report for Mylan

Mylan N.V. is an American global generic and specialty pharmaceuticals company registered in the Netherlands, with principal executive offices in Hatfield, Hertfordshire, UK and global headquarters in Canonsburg, Pennsylvania, US. In 2007, Mylan acquired a controlling interest in India-based Matrix Laboratories Limited, a top producer of active pharmaceutical ingredients (APIs) for generic drugs, and the generics business of Germany-based Merck KGaA. Through these acquisitions, Mylan grew from the third-largest generic and pharmaceuticals company in the United States to the second-largest generic and specialty pharmaceuticals company in the world.Mylan went public on the OTC market in February 1973. It is listed on the NASDAQ, and its shares have been a component of NASDAQ Biotechnology, NASDAQ 100, and the S&P 500 indices.The company develops and produces medicines for a wide range of medical disciplines, including oncology, anaphylaxis, antiretrovirals, cardiovascular, respiratory, dermatology, immunology, anesthesia and pain management, infectious disease, gastroenterology, diabetology/endocrinology, and women's healthcare.In 2016, Mylan's pricing of the EpiPen, an epinephrine autoinjector, became controversial and was widely referred to as "price gouging". As a result, investigations were opened into whether Mylan had misclassified the EpiPen under the Medicaid Drug Rebate Program, a common form of pharmaceutical fraud.

Mylan Data Breaches and Security News

Relevant news, breaches and security articles relating to Mylan.
Coming soon.
No recent security news.

More security reports

Compare Mylan's security performance with other companies.
Deliver icon

Sign up to our newsletter

Get the latest curated cybersecurity news, breaches, events and updates in your inbox every week.
Abstract shapeAbstract shape
Free instant security score

How secure is your organization?

Request a free cybersecurity report to discover key risks on your website, email, network, and brand.
  • Check icon
    Instant insights you can act on immediately
  • Check icon
    13 risk factors, including email security, SSL, DNS health, open ports and common vulnerabilities
Website Security scan resultsWebsite Security scan ratingAbstract shape

Book a free demo

Book a free, personalized onboarding call with one of our cybersecurity experts.